XML 33 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - CAD ($)
Total
Share Capital [member]
Reserves [member]
Accumulated other comprehensive Income [member]
Accumulated other comprehensive Income [member]
Impact of Adopting IFRS 9 [member]
Retained earnings [member]
Retained earnings [member]
Impact of Adopting IFRS 9 [member]
Non-controlling Interests [member]
Beginning balance at Dec. 31, 2016 $ 119,006,266 $ 125,735,515 $ 17,005,665     $ (32,743,616)   $ 9,008,702
Beginning balance, shares at Dec. 31, 2016   306,190,287            
Statement [LineItems]                
Exercise of warrants 2,857,143 $ 2,857,143            
Exercise of warrants, shares   5,714,286            
Exercise of options 1,128,032 $ 1,981,132 (853,100)          
Exercise of options, shares   1,424,445            
Share issuance costs (2,519,632) $ (2,519,632)            
Issue of shares for cash from private placement 62,745,000 $ 62,745,000            
Issue of shares for cash from private placement, shares   24,146,424            
Issue of shares on convertible debenture financing 2,258,820 $ 2,258,820            
Issue of shares on convertible debenture financing, shares   869,271            
Issue of shares on convertible debenture interest payment 2,919,876 $ 2,919,876            
Issue of shares on convertible debenture interest payment, shares   883,533            
Issue of shares for exploration and evaluation assets 333,330 $ 333,330            
Issue of shares for exploration and evaluation assets, shares   111,110            
Share-based payments 12,493,458   12,493,458          
Reserve re-allocation for expired warrants     (595,964)     595,964    
Issue of shares of subsidiary to non-controlling interests 3,949,022         147,591   3,801,431
Profit (loss) for the period (56,830,610)         (56,038,329)   (792,281)
Ending balance at Dec. 31, 2017 148,340,705 $ 196,311,184 28,050,059     (88,038,390)   12,017,852
Ending balance, shares at Dec. 31, 2017   339,339,356            
Statement [LineItems]                
Exercise of options 5,074,334 $ 8,351,206 (3,276,872)          
Exercise of options, shares   10,458,334            
Issue of shares on convertible debenture interest payment 4,048,745 $ 4,048,745            
Issue of shares on convertible debenture interest payment, shares   1,439,372            
Share-based payments 16,855,862   16,855,862          
Issue of shares of subsidiary to non-controlling interests 5,514,517         122,466   5,392,051
Profit (loss) for the period 1,491,606         2,269,689   (778,083)
Other comprehensive income 600,821     $ 600,821        
Ending balance at Dec. 31, 2018 $ 181,926,590 $ 208,711,135 $ 41,629,049 $ 97,675 $ (503,146) $ (85,143,089) $ 503,146 $ 16,631,820
Ending balance, shares at Dec. 31, 2018   351,237,062